Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Osteoporosis

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 169 articles: HTML format

Single Articles

July 2021
1. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
   Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
   J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
   PubMed     Abstract available
   
   
   
2. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
   Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
   J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
   PubMed     Abstract available
   
   
   
3. WARD LM, Ma J, Robinson ME, Scharke M, et al
   Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
   J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
   PubMed     Abstract available
   
   
   
4. WARD LM, Choudhury A, Alos N, Cabral DA, et al
   Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
   J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
   PubMed     Abstract available
   
   
   
5. LING CW, Miao Z, Xiao ML, Zhou H, et al
   The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
   J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. MITCHELL A, Fall T, Melhus H, Lind L, et al
   Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
   J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
   PubMed     Abstract available
   
   
   June 2021
7. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
   Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
   J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. CHAPURLAT R
   Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
   J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
   PubMed    
   
   
   May 2021
9. KIM JA, Lee JS, Song E, Roh E, et al
   Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
   J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. 
    Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    PubMed    
    
    
    April 2021
12. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    PubMed     Abstract available
    
    
    
13. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2021
14. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    PubMed     Abstract available
    
    
    
17. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2021
18. 
    Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    PubMed    
    
    
    
19. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    PubMed     Abstract available
    
    
    
20. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2021
21. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    PubMed    
    
    
    
22. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    PubMed     Abstract available
    
    
    
23. 
    Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    PubMed    
    
    
    November 2020
24. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    PubMed     Abstract available
    
    
    
25. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2020
27. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    PubMed     Abstract available
    
    
    
28. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    PubMed     Abstract available
    
    
    
29. COHEN A, Shiau S, Nair N, Recker RR, et al
    Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    September 2020
30. LANGDAHL B
    Treatment of premenopausal women with osteoporosis.
    J Clin Endocrinol Metab. 2020 Sep 22. pii: 5910063. doi: 10.1210.
    PubMed    
    
    
    
31. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    PubMed     Abstract available
    
    
    
32. VAN SANTEN SS, Olsson DS, Hammarstrand C, Wijnen M, et al
    Body composition and bone mineral density in craniopharyngioma patients: a longitudinal study over 10 years.
    J Clin Endocrinol Metab. 2020 Sep 1. pii: 5900043. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2020
33. QU Z, Yang F, Hong J, Wang W, et al
    Parathyroid hormone and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 Aug 22. pii: 5896008. doi: 10.1210.
    PubMed     Abstract available
    
    
    
34. LIU Y, Shen H, Greenbaum J, Liu A, et al
    Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.
    J Clin Endocrinol Metab. 2020 Aug 21. pii: 5895512. doi: 10.1210.
    PubMed     Abstract available
    
    
    
35. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    
    
    
    July 2020
36. RODRIGUEZ AJ, Ernst MT, Nybo M, Prieto-Alhambra D, et al
    Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density.
    J Clin Endocrinol Metab. 2020 Jul 27. pii: 5876920. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873223. doi: 10.1210.
    PubMed    
    
    
    
38. GONG M, Huang G, Xu C
    Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873220. doi: 10.1210.
    PubMed    
    
    
    
39. RACHNER TD, Gobel A, Jaschke NP, Hofbauer LC, et al
    Challenges in preventing bone loss induced by aromatase inhibitors.
    J Clin Endocrinol Metab. 2020 Jul 16. pii: 5872610. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. COSMAN F, Peterson LR, Towler DA, Mitlak B, et al
    Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial.
    J Clin Endocrinol Metab. 2020 Jul 13. pii: 5870711. doi: 10.1210.
    PubMed     Abstract available
    
    
    
41. ALAJLOUNI D, Bliuc D, Tran T, Eisman JA, et al
    Decline in muscle strength and performance predicts fracture risk in elderly women and men.
    J Clin Endocrinol Metab. 2020 Jul 8. pii: 5868761. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2020
42. KINDLER JM, Kalkwarf HJ, Lappe JM, Gilsanz V, et al
    Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study.
    J Clin Endocrinol Metab. 2020 Jun 19. pii: 5860168. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. MAZZIOTTI G, Betella N, Lania AG
    Letter to the Editor: ["Delayed Denosumab Injections and Bone Mineral Density Response: En Electronic Health Record-Based Study"].
    J Clin Endocrinol Metab. 2020 Jun 17. pii: 5859156. doi: 10.1210.
    PubMed    
    
    
    
44. YAVROPOULOU MP, Anastasilakis AD, Makras P, Papatheodorou A, et al
    Serum profile of microRNAs linked to bone metabolism during sequential treatment for postmenopausal osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 10. pii: 5855767. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. ZHANG L, Peng TL, Wang L, Meng XH, et al
    Network-Based Transcriptome-Wide Expression Study for Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 1. pii: 5850085. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2020
46. PEPE J, Body JJ, Hadji P, McCloskey E, et al
    Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846185. doi: 10.1210.
    PubMed     Abstract available
    
    
    
47. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843473. doi: 10.1210.
    PubMed    
    
    
    
48. WATTS NB
    Letter to the editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843452. doi: 10.1210.
    PubMed    
    
    
    
49. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    April 2020
50. NGUYEN TV
    Toward the era of precision fracture risk assessment.
    J Clin Endocrinol Metab. 2020 Apr 21. pii: 5823064. doi: 10.1210.
    PubMed    
    
    
    
51. VAN SANTEN SS, Olsson DS, van den Heuvel-Eibrink MM, Wijnen M, et al
    Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    
52. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    
53. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    March 2020
54. JAIN RK, Weiner MG, Zhao H, Vokes T, et al
    Comorbid conditions and GFR predict non-vertebral fractures in patients with diabetes in an ethnic-specific manner.
    J Clin Endocrinol Metab. 2020 Mar 20. pii: 5810272. doi: 10.1210.
    PubMed     Abstract available
    
    
    
55. SHOBACK D, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    
56. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    PubMed    
    
    
    February 2020
57. LI GH, Chau YP, Cheung CL
    Response to Letter to the Editor: Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740110. doi: 10.1210.
    PubMed    
    
    
    
58. KAWADA T
    Letter to the Editor: "Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study".
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740117. doi: 10.1210.
    PubMed    
    
    
    January 2020
59. LUKERT BP
    Which Drug Next? Sequential Therapy for Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jan 10. pii: 5700360. doi: 10.1210.
    PubMed     Abstract available
    
    
    
60. YANG WP, Chang HH, Li HY, Lai YC, et al
    Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.
    J Clin Endocrinol Metab. 2020 Jan 7. pii: 5697444. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2020 Jan 3. pii: 5695688. doi: 10.1210.
    PubMed     Abstract available
    
    
    
62. LYU H, Zhao SS, Yoshida K, Tedeschi SK, et al
    Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study.
    J Clin Endocrinol Metab. 2020 Jan 2. pii: 5693392. doi: 10.1210.
    PubMed     Abstract available
    
    
    
63. 
    CORRIGENDUM for "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    
    
    
    
64. DING L, Hu J, Wang D, Liu Q, et al
    Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    December 2019
65. EL-HAJJ FULEIHAN G
    Building Bridges to Address the Osteoporosis Crisis.
    J Clin Endocrinol Metab. 2019 Dec 31. pii: 5691193. doi: 10.1210.
    PubMed    
    
    
    
66. MA J, Lin X, Chen C, Li S, et al
    Circulating miR-181c-5p and miR-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 24. pii: 5686162. doi: 10.1210.
    PubMed     Abstract available
    
    
    
67. WARD LM, Weber DR, Munns CF, Hogler W, et al
    A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.
    J Clin Endocrinol Metab. 2019 Dec 22. pii: 5684884. doi: 10.1210.
    PubMed     Abstract available
    
    
    
68. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. LI M, Yao S, Duan YY, Zhang YJ, et al
    Transcription Factor Enrichment Analysis in Enhancers Identifies EZH2 as A Susceptibility Gene for Osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 13. pii: 5675148. doi: 10.1210.
    PubMed     Abstract available
    
    
    
70. MAIMOUN L, Garnero P, Mura T, Nocca D, et al
    Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women.
    J Clin Endocrinol Metab. 2019 Dec 10. pii: 5672712. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2019
71. CHAU YP, Au PCM, Li GHY, Sing CW, et al
    Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2019 Nov 21. pii: 5637088. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. BLUMENFELD Z, Lavie G
    Menopausal transition bone loss- what are the practical implications.
    J Clin Endocrinol Metab. 2019 Nov 19. pii: 5629158. doi: 10.1210.
    PubMed    
    
    
    
73. GONZALEZ RODRIGUEZ E, Stuber M, Del Giovane C, Feller M, et al
    Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study.
    J Clin Endocrinol Metab. 2019 Nov 8. pii: 5614779. doi: 10.1210.
    PubMed     Abstract available
    
    
    
74. HALPER-STROMBERG E, Gallo T, Champakanath A, Taki I, et al
    Bone Mineral Density across the Life-Span in Patients with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Nov 2. pii: 5611085. doi: 10.1210.
    PubMed     Abstract available
    
    
    
75. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610884. doi: 10.1210.
    PubMed     Abstract available
    
    
    
76. RAMCHAND SK, David NL, Leder BZ, Tsai JN, et al
    Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610890. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2019
77. ANAGNOSTIS P, Kenanidis E, Potoupnis M, Tsiridis E, et al
    Letter to the Editor: "Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline."
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607923. doi: 10.1210.
    PubMed    
    
    
    
78. KENDLER D, Chines A, Clark P, Ebeling PR, et al
    Bone Mineral Density After Transitioning From Denosumab to Alendronate.
    J Clin Endocrinol Metab. 2019 Oct 26. pii: 5607536. doi: 10.1210.
    PubMed     Abstract available
    
    
    
79. LI GH, Robinson-Cohen C, Sahni S, Au PC, et al
    Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density.
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606940. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. LYU H, Zhao SS, Solomon DH
    Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606941. doi: 10.1210.
    PubMed    
    
    
    
81. GEUSENS P, Marin F, Kendler DL
    Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606939. doi: 10.1210.
    PubMed    
    
    
    
82. SUGIYAMA T
    Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602688. doi: 10.1210.
    PubMed    
    
    
    
83. MURAI IH, Roschel H, Gualano B
    Response to Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602687. doi: 10.1210.
    PubMed    
    
    
    
84. MERLOTTI D, Rendina D, Muscariello R, Picchioni T, et al
    PREVENTIVE ROLE OF VITAMIN D SUPPLEMENTATION FOR ACUTE PHASE REACTION AFTER BISPHOSPHONATE INFUSION IN PAGET'S DISEASE.
    J Clin Endocrinol Metab. 2019 Oct 22. pii: 5601913. doi: 10.1210.
    PubMed     Abstract available
    
    
    
85. CHILOIRO S, Antonella G, Frara S, Bima C, et al
    Effects of Pegvisomant and Pasireotide LAR on vertebral fractures in acromegaly resistant to First-Generation SRLs.
    J Clin Endocrinol Metab. 2019 Oct 15. pii: 5588033. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2019
86. ZHAO Z, Wang L, Fu Z, Ji L, et al
    The prevalence of osteoporosis tested by quantitative computed tomography in patients with different glucose tolerances.
    J Clin Endocrinol Metab. 2019 Sep 23. pii: 5572675. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2019
87. SUGIYAMA T
    Letter to the Editor: "Comparison of teriparatide and denosumab in patients switching from long-term bisphosphonate use".
    J Clin Endocrinol Metab. 2019 Aug 13. pii: 5548914. doi: 10.1210/jc.2019-01650.
    PubMed    
    
    
    
88. MAJOOR BCJ, Papapoulos SE, Dijkstra PDS, Fiocco M, et al
    Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates.
    J Clin Endocrinol Metab. 2019 Aug 7. pii: 5544499. doi: 10.1210/jc.2018-02543.
    PubMed     Abstract available
    
    
    
89. JAIN RK, Weiner MG, Zhao H, Williams KJ, et al
    Diabetes-related fracture risk is different in African Americans when compared to Hispanics and Caucasians.
    J Clin Endocrinol Metab. 2019 Aug 1. pii: 5540967. doi: 10.1210/jc.2019-00931.
    PubMed     Abstract available
    
    
    July 2019
90. MURAI IH, Roschel H, Dantas WS, Gil S, et al
    Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial.
    J Clin Endocrinol Metab. 2019 Jul 19. pii: 5535689. doi: 10.1210/jc.2019-00074.
    PubMed     Abstract available
    
    
    
91. MAI HT, Tran TS, Ho-Le TP, Center JR, et al
    Response to Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 Jul 12. pii: 5530991. doi: 10.1210/jc.2019-01457.
    PubMed    
    
    
    
92. WEN Z, Chen R, Liu H
    Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 Jul 12. pii: 5530988. doi: 10.1210/jc.2019-01326.
    PubMed    
    
    
    
93. LYU H, Zhao SS, Yoshida K, Tedeschi SK, et al
    Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use.
    J Clin Endocrinol Metab. 2019 Jul 2. pii: 5526755. doi: 10.1210/jc.2019-00924.
    PubMed     Abstract available
    
    
    June 2019
94. CAI S, Zhu J, Sun L, Fan C, et al
    Association between urinary triclosan with bone mass density and osteoporosis in the US adult women, 2005-2010.
    J Clin Endocrinol Metab. 2019 Jun 25. pii: 5522022. doi: 10.1210/jc.2019-00576.
    PubMed     Abstract available
    
    
    May 2019
95. MAI HT, Tran TS, Ho-Le TP, Center JR, et al
    Response to Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492494. doi: 10.1210/jc.2019-01016.
    PubMed    
    
    
    
96. KHOSRAVI A, Mansournia MA
    Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492491. doi: 10.1210/jc.2019-00935.
    PubMed    
    
    
    
97. SUGIYAMA T
    Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2019 May 16. pii: 5489446. doi: 10.1210/jc.2019-01017.
    PubMed    
    
    
    
98. BARRIONUEVO P, Gionfriddo MR, Castaneda-Guarderas A, Zeballos-Palacios C, et al
    Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.
    J Clin Endocrinol Metab. 2019;104:1631-1636.
    PubMed     Abstract available
    
    
    
99. EASTELL R, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1595-1622.
    PubMed     Abstract available
    
    
    
100. BARRIONUEVO P, Kapoor E, Asi N, Alahdab F, et al
     Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
     J Clin Endocrinol Metab. 2019;104:1623-1630.
     PubMed     Abstract available
     
     
     
101. ALOIA JF, Mikhail M, Fazzari M, Islam S, et al
     Physical Performance and Vitamin D in Elderly Black Women-The PODA Randomized Clinical Trial.
     J Clin Endocrinol Metab. 2019;104:1441-1448.
     PubMed     Abstract available
     
     
     April 2019
102. EASTELL R, Rosen CJ
     Response to Letter to the Editor: Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
     J Clin Endocrinol Metab. 2019 Apr 18. pii: 5473527. doi: 10.1210/jc.2019-00777.
     PubMed    
     
     
     
103. RODRIGUEZ EG, Lamy O
     Letter to the Editor "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline."
     J Clin Endocrinol Metab. 2019 Apr 18. pii: 5473525. doi: 10.1210/jc.2019-00747.
     PubMed    
     
     
     
104. PAZIANAS M
     Letter to the Editor: Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.
     J Clin Endocrinol Metab. 2019 Apr 16. pii: 5450711. doi: 10.1210/jc.2019-00785.
     PubMed    
     
     
     
105. WON SH, Kim JH
     Letter to the Editor: Evidence of a causal effect of estradiol on fracture risk in men.
     J Clin Endocrinol Metab. 2019 Apr 16. pii: 5450710. doi: 10.1210/jc.2019-00736.
     PubMed    
     
     
     
106. MAI HT, Tran TS, Ho-Le TP, Center JR, et al
     Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
     J Clin Endocrinol Metab. 2019 Apr 5. pii: 5427152. doi: 10.1210/jc.2018-02614.
     PubMed     Abstract available
     
     
     March 2019
107. REID LJ, Muthukrishnan B, Patel D, Seckl JR, et al
     Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism.
     J Clin Endocrinol Metab. 2019 Mar 27. pii: 5419224. doi: 10.1210/jc.2018-02483.
     PubMed     Abstract available
     
     
     
108. BRISTOW SM, Horne AM, Gamble GD, Mihov B, et al
     Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.
     J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393287. doi: 10.1210/jc.2019-00111.
     PubMed     Abstract available
     
     
     
109. CHEN SC, Shepherd S, McMillan M, McNeilly J, et al
     Skeletal Fragility & Its Clinical Determinants In Children With Type 1 Diabetes.
     J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371250. doi: 10.1210/jc.2019-00084.
     PubMed     Abstract available
     
     
     February 2019
110. NAPOLI N, Conte C, Pedone C, Strotmeyer ES, et al
     Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults.
     J Clin Endocrinol Metab. 2019 Feb 25. pii: 5364431. doi: 10.1210/jc.2018-02539.
     PubMed     Abstract available
     
     
     
111. WATTS NB, Grbic JT, Binkley N, Papapoulos S, et al
     Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated With Denosumab for up to 10 Years.
     J Clin Endocrinol Metab. 2019 Feb 13. pii: 5316168. doi: 10.1210/jc.2018-01965.
     PubMed     Abstract available
     
     
     January 2019
112. CAULEY JA, Ruppert K, Lian Y, Finkelstein JS, et al
     Serum Sex Hormones and the Risk of Fracture across the Menopausal Transition: Study of Women's Health Across the Nation.
     J Clin Endocrinol Metab. 2019 Jan 23. pii: 5298592. doi: 10.1210/jc.2018-02047.
     PubMed     Abstract available
     
     
     
113. VAVANIKUNNEL J, Charlier S, Becker C, Schneider C, et al
     Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study.
     J Clin Endocrinol Metab. 2019 Jan 16. pii: 5244186. doi: 10.1210/jc.2018-01879.
     PubMed     Abstract available
     
     
     December 2018
114. LYU H, Jundi B, Xu C, Tedeschi SK, et al
     Comparison of denosumab vs. bisphosphonates in osteoporosis patients: A meta-analysis of randomized controlled trials.
     J Clin Endocrinol Metab. 2018 Dec 10. pii: 5235617. doi: 10.1210/jc.2018-02236.
     PubMed     Abstract available
     
     
     September 2018
115. KINDLER JM, Lappe JM, Gilsanz V, Oberfield S, et al
     Lumbar Spine Bone Mineral Apparent Density in Children: Results from the Bone Mineral Density in Childhood Study.
     J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107297. doi: 10.1210/jc.2018-01693.
     PubMed     Abstract available
     
     
     
116. TOURNIS S, Trovas G, Triantafyllopoulos IK, Balanika AP, et al
     Letter to the editor. Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy.
     J Clin Endocrinol Metab. 2018 Sep 26. pii: 5106939. doi: 10.1210/jc.2018-01638.
     PubMed    
     
     
     
117. JEON YK, Kim IJ, Kim K
     Reply to a Letter to the Editor: "Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy".
     J Clin Endocrinol Metab. 2018 Sep 26. pii: 5106936. doi: 10.1210/jc.2018-02004.
     PubMed    
     
     
     
118. MA J, Siminoski K, Alos N, Halton J, et al
     Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment for leukemia.
     J Clin Endocrinol Metab. 2018 Sep 20. pii: 5103424. doi: 10.1210/jc.2018-01083.
     PubMed     Abstract available
     
     
     
119. NETHANDER M, Vandenput L, Eriksson AL, Windahl S, et al
     Evidence of a Causal Effect of Estradiol on Fracture Risk in Men.
     J Clin Endocrinol Metab. 2018 Sep 11. pii: 5094017. doi: 10.1210/jc.2018-00934.
     PubMed     Abstract available
     
     
     July 2018
120. HAMILTON EJ, Drinkwater JJ, Chubb SAP, Rakic V, et al
     A ten-year prospective study of bone mineral density and bone turnover in males and females with type 1 diabetes.
     J Clin Endocrinol Metab. 2018 Jul 18. pii: 5055538. doi: 10.1210/jc.2018-00850.
     PubMed     Abstract available
     
     
     
121. LIN SM, Wang JH, Liang CC, Huang HK, et al
     Statin use is associated with decreased osteoporosis and fracture risks in stroke patients.
     J Clin Endocrinol Metab. 2018 Jul 2. pii: 5047290. doi: 10.1210/jc.2018-00652.
     PubMed     Abstract available
     
     
     
122. SHEN J, Griffith JF, Zhu TY, Tang P, et al
     Bone Mass, Microstucture And Strength Can Discriminate Vertebral Fracture In Patients on Long-Term Steroid Treatment.
     J Clin Endocrinol Metab. 2018 Jul 2. pii: 5047293. doi: 10.1210/jc.2018-00490.
     PubMed     Abstract available
     
     
     June 2018
123. KIM K, Kim IJ, Pak K, Kim SJ, et al
     Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy.
     J Clin Endocrinol Metab. 2018 Jun 21. pii: 5041930. doi: 10.1210/jc.2017-02704.
     PubMed     Abstract available
     
     
     
124. LEWIECKI EM, Blicharski T, Goemaere S, Lippuner K, et al
     A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis.
     J Clin Endocrinol Metab. 2018 Jun 20. pii: 5040365. doi: 10.1210/jc.2017-02163.
     PubMed     Abstract available
     
     
     May 2018
125. KIM SY, Kong IG, Lim H, Choi HG, et al
     Increased risk of sudden sensory neural hearing loss in osteoporosis: A longitudinal follow up study.
     J Clin Endocrinol Metab. 2018 May 28. pii: 5005943. doi: 10.1210/jc.2018-00717.
     PubMed     Abstract available
     
     
     
126. BONE HG, Cosman F, Miller PD, Williams GC, et al
     ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
     J Clin Endocrinol Metab. 2018 May 24. pii: 5001732. doi: 10.1210/jc.2018-00163.
     PubMed     Abstract available
     
     
     
127. SUGIYAMA T
     Letter to the Editor: Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis.
     J Clin Endocrinol Metab. 2018 May 15. pii: 4995803. doi: 10.1210/jc.2018-00886.
     PubMed    
     
     
     April 2018
128. DEMPSTER DW, Brown JP, Fahrleitner-Pammer A, Kendler D, et al
     Effects of Long-term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
     J Clin Endocrinol Metab. 2018 Apr 16. pii: 4970149. doi: 10.1210/jc.2017-02669.
     PubMed     Abstract available
     
     
     March 2018
129. LIU L, Wen Y, Zhang L, Xu P, et al
     Assessing the associations of blood metabolites with osteoporosis: a Mendelian randomization study.
     J Clin Endocrinol Metab. 2018 Mar 1. pii: 4916908. doi: 10.1210/jc.2017-01719.
     PubMed     Abstract available
     
     
     
130. MAKITIE RE, Hackl M, Niinimaki R, Kakko S, et al
     Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
     J Clin Endocrinol Metab. 2018 Mar 1. pii: 4916912. doi: 10.1210/jc.2017-02585.
     PubMed     Abstract available
     
     
     February 2018
131. KHOSLA S, Farr JN, Kirkland JL
     Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis.
     J Clin Endocrinol Metab. 2018 Feb 7. pii: 4841935. doi: 10.1210/jc.2017-02694.
     PubMed     Abstract available
     
     
     
132. KIM BJ, Kwak MK, Ahn SH, Kim H, et al
     Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess.
     J Clin Endocrinol Metab. 2018;103:615-621.
     PubMed     Abstract available
     
     
     January 2018
133. 
     CORRIGENDUM FOR "Identification of Novel Potentially Pleiotropic Variants Associated With Osteoporosis and Obesity Using the cFDR Method".
     J Clin Endocrinol Metab. 2018 Jan 22. pii: 4819317. doi: 10.1210/jc.2018-00141.
     PubMed    
     
     
     
134. GOSSIEL F, Scott JR, Paggiosi MA, Naylor KE, et al
     The effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis.
     J Clin Endocrinol Metab. 2018 Jan 22. pii: 4819314. doi: 10.1210/jc.2017-00283.
     PubMed     Abstract available
     
     
     
135. BERGMAN J, Nordstrom A, Nordstrom P
     Alendronate Use and the Risk of Nonvertebral Fracture During Glucocorticoid Therapy: A Retrospective Cohort Study.
     J Clin Endocrinol Metab. 2018;103:306-313.
     PubMed     Abstract available
     
     
     December 2017
136. SOUCEK O, Schonau E, Lebl J, Willnecker J, et al
     A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls with Turner Syndrome.
     J Clin Endocrinol Metab. 2017 Dec 28. pii: 4780815. doi: 10.1210/jc.2017-02381.
     PubMed     Abstract available
     
     
     
137. ANASTASILAKIS AD, Makras P, Pikilidou M, Tournis S, et al
     Changes of circulating micro-RNAs in response to treatment with teriparatide or denosumab in postmenopausal osteoporosis.
     J Clin Endocrinol Metab. 2017 Dec 22. pii: 4772360. doi: 10.1210/jc.2017-02406.
     PubMed     Abstract available
     
     
     November 2017
138. HU Y, Tan LJ, Chen XD, Liu Z, et al
     Identification of Novel Potentially-pleiotropic Variants Associated With Osteoporosis and Obesity Using cFDR method.
     J Clin Endocrinol Metab. 2017 Nov 14. doi: 10.1210/jc.2017-01531.
     PubMed     Abstract available
     
     
     
139. MAZZIOTTI G, Formenti AM, Frara S, Olivetti R, et al
     HIGH PREVALENCE OF RADIOLOGICAL VERTEBRAL FRACTURES IN WOMEN ON TSH-SUPPRESSIVE THERAPY FOR THYROID CARCINOMA.
     J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01986.
     PubMed     Abstract available
     
     
     
140. LEE RH, Sloane R, Pieper C, Lyles KW, et al
     Clinical fractures among older men with diabetes are mediated by diabetic complications.
     J Clin Endocrinol Metab. 2017 Nov 1. doi: 10.1210/jc.2017-01593.
     PubMed     Abstract available
     
     
     
141. SINGH-OSPINA N, Maraka S, Rodriguez-Gutierrez R, Davidge-Pitts C, et al
     Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis.
     J Clin Endocrinol Metab. 2017;102:3904-3913.
     PubMed     Abstract available
     
     
     September 2017
142. SAKKA S, Gafni RI, Davies JH, Clarke B, et al
     Bone structural characteristics and response to bisphosphonate treatment in children with Hajdu-Cheney Syndrome.
     J Clin Endocrinol Metab. 2017 Sep 8. doi: 10.1210/jc.2017-01102.
     PubMed     Abstract available
     
     
     
143. SMEETS CCJ, van der Steen M, Renes JS, Hokken-Koelega ACS, et al
     Bone Mineral Density After Cessation of GH Treatment in Young Adults Born SGA: A 5-Year Longitudinal Study.
     J Clin Endocrinol Metab. 2017;102:3508-3516.
     PubMed     Abstract available
     
     
     July 2017
144. SWANSON C, Shea SA, Wolfe P, Cain SW, et al
     Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans.
     J Clin Endocrinol Metab. 2017 Jul 26. doi: 10.1210/jc.2017-01147.
     PubMed     Abstract available
     
     
     
145. BALASURIYA CND, Evensen KAI, Mosti MP, Brubakk AM, et al
     Peak Bone Mass and Bone Microarchitecture in Adults Born With Low Birth Weight Preterm or at Term: A Cohort Study.
     J Clin Endocrinol Metab. 2017;102:2491-2500.
     PubMed     Abstract available
     
     
     June 2017
146. PASCHOU S, Dede AD, Anagnostis PG, Vryonidou A, et al
     Type 2 diabetes and osteoporosis: a guide to optimal management.
     J Clin Endocrinol Metab. 2017 Jun 21. doi: 10.1210/jc.2017-00042.
     PubMed     Abstract available
     
     
     
147. LAMY O, Gonzalez-Rodriguez E, Aubry-Rozier B
     Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
     J Clin Endocrinol Metab. 2017;102:2112.
     PubMed    
     
     
     
148. RAO SD, Qiu S, Dhaliwal R, Bhadada SK, et al
     Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
     J Clin Endocrinol Metab. 2017;102:2111.
     PubMed    
     
     
     May 2017
149. VERROKEN C, Pieters W, Beddeleem L, Goemaere S, et al
     CORTICAL BONE SIZE DEFICIT IN ADULT PATIENTS WITH TYPE 1 DIABETES MELLITUS.
     J Clin Endocrinol Metab. 2017 May 22. doi: 10.1210/jc.2017-00620.
     PubMed     Abstract available
     
     
     
150. SCHORR M, Marengi DA, Pulumo R, Yu E, et al
     Oxytocin and its relationship to body composition, bone mineral density and hip geometry across the weight spectrum
     J Clin Endocrinol Metab. 2017 May 10. doi: 10.1210/jc.2016-3963.
     PubMed     Abstract available
     
     
     
151. OHLSSON C, Sundh D, Wallerek A, Nilsson M, et al
     Response to Letter: "Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men".
     J Clin Endocrinol Metab. 2017;102:1782.
     PubMed    
     
     
     
152. ZHANG Y, Xiao H, Sheng ZF
     Letter to the Editor: "Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men".
     J Clin Endocrinol Metab. 2017;102:1780-1781.
     PubMed    
     
     
     April 2017
153. GONZALEZ RODRIGUEZ E, Lamy O, Stoll D, Metzger M, et al
     High evening cortisol level is associated with low TBS and increased prevalent vertebral fractures. OsteoLaus study.
     J Clin Endocrinol Metab. 2017 Apr 4. doi: 10.1210/jc.2016-3804.
     PubMed     Abstract available
     
     
     
154. WESSELING-PERRY K, Makitie RE, Valimaki VV, Laine T, et al
     Osteocyte protein expression is altered in low-turnover osteoporosis caused by mutations in WNT1 and PLS3.
     J Clin Endocrinol Metab. 2017 Apr 3. doi: 10.1210/jc.2017-00099.
     PubMed     Abstract available
     
     
     March 2017
155. CHEMAITILLY W, Li Z, Krasin MJ, Brooke RJ, et al
     Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort.
     J Clin Endocrinol Metab. 2017 Mar 24. doi: 10.1210/jc.2016-3723.
     PubMed     Abstract available
     
     
     
156. VALDERRABANO RJ, Lee J, Lui LY, Hoffman AR, et al
     Older Men with Anemia Have Increased Fracture Risk Independent of Bone Mineral Density.
     J Clin Endocrinol Metab. 2017 Mar 20. doi: 10.1210/jc.2017-00266.
     PubMed     Abstract available
     
     
     
157. WANG Y, Wactawski-Wende J, Sucheston-Campbell LE, Preus L, et al
     Gene-hormone therapy interaction and fracture risk in postmenopausal women.
     J Clin Endocrinol Metab. 2017 Mar 6. doi: 10.1210/jc.2016-2936.
     PubMed     Abstract available
     
     
     
158. BURR DB, Lane JE, Howe TS, Ng AC, et al
     Response to PD Miller, Underdiagnosis and Undertreatment of Osteoporosis: The Battle To Be Won.
     J Clin Endocrinol Metab. 2017;102:1088-1089.
     PubMed    
     
     
     
159. TROVAS G
     Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Nine Clinical Cases Report.
     J Clin Endocrinol Metab. 2017;102:1086.
     PubMed    
     
     
     February 2017
160. NOTSU M, Yamauchi M, Yamamoto M, Nawata K, et al
     Primary aldosteronism as a risk factor for vertebral fracture.
     J Clin Endocrinol Metab. 2017 Feb 9. doi: 10.1210/jc.2016-3206.
     PubMed    
     
     
     January 2017
161. VUORIMIES I, Mayranpaa MK, Valta H, Kroger H, et al
     Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children with Osteogenesis Imperfecta.
     J Clin Endocrinol Metab. 2017 Jan 17. doi: 10.1210/jc.2016-3745.
     PubMed     Abstract available
     
     
     
162. WATTS NB, Cauley JA, Jackson RD, LaCroix AZ, et al
     No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.
     J Clin Endocrinol Metab. 2017;102:302-308.
     PubMed     Abstract available
     
     
     November 2016
163. OHLSSON C, Sundh D, Wallerek A, Nilsson M, et al
     Cortical bone area predicts incident fractures independently of areal bone mineral density in older men.
     J Clin Endocrinol Metab. 2016 Nov 22:jc20163177.
     PubMed     Abstract available
     
     
     
164. PAPADAKIS G, Hans D, Gonzalez-Rodriguez E, Vollenweider P, et al
     The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
     J Clin Endocrinol Metab. 2016 Nov 17:jc20162695.
     PubMed     Abstract available
     
     
     
165. CHAWLA H, Saha S, Kandaswamy D, Sharma R, et al
     Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up.
     J Clin Endocrinol Metab. 2016 Nov 4:jc20163292.
     PubMed     Abstract available
     
     
     October 2016
166. VALIMAKI VV, Makitie O, Pereira R, Laine C, et al
     Teriparatide Treatment in Patients with WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis - A Pilot Study.
     J Clin Endocrinol Metab. 2016 Oct 12:jc20162423.
     PubMed     Abstract available
     
     
     
167. LAMY O, Gonzalez-Rodriguez E, Stoll D, Hans D, et al
     Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
     J Clin Endocrinol Metab. 2016 Oct 12:jc20163170.
     PubMed     Abstract available
     
     
     September 2016
168. ESCHE J, Johner S, Shi L, Schonau E, et al
     Urinary citrate, an index of acid-base status, predicts bone strength in youths and fracture risk in adult females.
     J Clin Endocrinol Metab. 2016 Sep 27:jc20162677.
     PubMed     Abstract available
     
     
     May 2016
169. SHANBHOGUE VV, Finkelstein JS, Bouxsein ML, Yu EW, et al
     Association between insulin resistance and bone structure in non-diabetic postmenopausal women.
     J Clin Endocrinol Metab. 2016 May 31:jc20161726.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: